Categories
Electric vehicles Energy Environment Finances Military

Parkinson’s Disease Pipeline Insight 2021

DelveInsight’s “Parkinson’s Disease Pipeline Insight, 2021” highlights the details around Parkinson’s disease. Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. The report provides disease overview, pipeline scenario and therapeutic assessment of the key pipeline therapies in this domain. The report also highlights the unmet needs with respect to the development of Parkinson’s disease.

Parkinson’s disease Overview

Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra.

Download free sample copy- https://www.delveinsight.com/sample-request/parkinsons-disease-pipeline-insight

List of Parkinson’s disease companies involved in the report

  • Cerevel Therapeutics
  • Abbvie
  • Roche
  • Kissei Pharmaceutical
  • AstraZeneca
  • Lundbeck A/S
  • Treefrog Therapeutics
  • And many others

Parkinson’s disease Symptoms

  • Tremor (trembling) in hands, arms, legs, jaw, or head
  • Stiffness of the limbs and trunk
  • Slowness of movement
  • Impaired balance and coordination, sometimes leading to falls

Parkinson’s disease Causes

Scientists believe a combination of genetic and environmental factors are the cause of Parkinson’s disease (PD). PD is an extremely diverse disorder. While no two people experience Parkinson’s the same way, there are some commonalities. PD affects about one million people in the United States and ten million worldwide. The main finding in brains of people with PD is loss of dopaminergic neurons in the area of the brain known as the substantia nigra.

Parkinson’s disease Diagnosis

There is no “one way” to diagnose Parkinson’s disease (PD). However, there are various symptoms and diagnostic tests used in combination. Making an accurate diagnosis of Parkinson’s — particularly in its early stages — is difficult, but a skilled practitioner can come to a reasoned conclusion that it is PD. People with Parkinson’s-like symptoms that result from other causes are sometimes said to have Parkinsonism. While these disorders initially may be misdiagnosed as Parkinson’s, certain medical tests, as well as response to drug treatment, may help to distinguish them from Parkinson’s.

Parkinson’s disease Treatment

Although there is no cure for Parkinson’s disease, medicines, surgical treatment, and other therapies can often relieve some symptoms. The main therapy for Parkinson’s is levodopa, also called L-dopa. Nerve cells use levodopa to make dopamine to replenish the brain’s dwindling supply. Usually, people take levodopa along with another medication called carbidopa. Carbidopa prevents or reduces some of the side effects of levodopa therapy—such as nausea, vomiting, low blood pressure, and restlessness—and reduces the amount of levodopa needed to improve symptoms.

Parkinson’s disease Pipeline Report

Parkinson’s Disease Pipeline Insights, 2021″ report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Parkinson’s Disease market. A detailed picture of the Parkinson’s disease pipeline landscape is provided, which includes the disease overview and Parkinson’s disease treatment guidelines.

.The assessment part of the report embraces in-depth Parkinson’s disease commercial assessment and clinical assessment of the Parkinson’s disease pipeline products from the pre-clinical developmental phase to the marketed phase. In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Parkinson’s Disease collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.

Download free sample copy- https://www.delveinsight.com/sample-request/parkinsons-disease-pipeline-insight

Table of content

  1. Report Introduction
  2. Parkinson’s Disease
  3. Parkinson’s Disease Current Treatment Patterns
  4. Parkinson’s Disease – DelveInsight’s Analytical Perspective
  5. Therapeutic Assessment
  6. Parkinson’s Disease Late Stage Products (Phase-III)
  7. Parkinson’s Disease Mid Stage Products (Phase-II)
  8. Early Stage Products (Phase-I)
  9. Pre-clinical Products and Discovery Stage Products
  10. Inactive Products
  11. Dormant Products
  12. Parkinson’s Disease Discontinued Products
  13. Parkinson’s Disease Product Profiles
  14. Parkinson’s Disease Key Companies
  15. Parkinson’s Disease Key Products
  16. Dormant and Discontinued Products
  17. Parkinson’s Disease Unmet Needs
  18. Parkinson’s Disease Future Perspectives
  19. Parkinson’s Disease Analyst Review
  20. Appendix
  21. Report Methodology

Parkinson’s disease Market Report Highlights

  • A better understanding of disease pathogenesis contributing to the development of novel therapeutics for Parkinson’s Disease.
  • In the coming years, the Parkinson’s Disease market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.
  • The companies and academics that are working to assess challenges and seek opportunities that could influence Parkinson’s Disease R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
  • A detailed portfolio of major pharma players who are involved in fueling the Parkinson’s Disease treatment market. Several potential therapies for Parkinson’s Disease are under investigation. With the expected launch of these emerging therapies, it is expected that there will be a significant impact on the Parkinson’s Disease market size in the coming years.
  • Our in-depth analysis of the pipeline assets (in early-stage, mid-stage and late stage of development for the treatment of Parkinson’s Disease) includes therapeutic assessment and comparative analysis. This will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

Also, read recommended services-

  1. Competitive Intelligence Services
  2. Business Consulting Services
  3. Consulting Services
  4. Portfolio Management Services
  5. Healthcare Consulting Services
  6. Due Diligence Consulting
  7. Pipeline Assessment Services
  8. Healthcare Consulting Solutions
  9. Healthcare due diligence services
  10. Healthcare Consulting

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact us

Yash

[email protected]

+91-9650213330

Categories
Finances

Parkinson’s Disease Treatment Market 2021: A brief review of size, share, trends, growth, etc.

Global Parkinson’s Disease Treatment Industry: with growing significant CAGR during Forecast 2021-2028

Latest Research Report on Parkinson’s Disease Treatment Market which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis

Understand the influence of COVID-19 on the Parkinson’s Disease Treatment Market with our analysts monitoring the situation across the globe. Request Now

The market research report on the global Parkinson’s Disease Treatment industry provides a comprehensive study of the various techniques and materials used in the production of Parkinson’s Disease Treatment market products. Starting from industry chain analysis to cost structure analysis, the report analyzes multiple aspects, including the production and end-use segments of the Parkinson’s Disease Treatment market products. The latest trends in the pharmaceutical industry have been detailed in the report to measure their impact on the production of Parkinson’s Disease Treatment market products.

Leading key players in the Parkinson’s Disease Treatment market are –
Acorda Therapeutics, Orion Pharmaceuticals, Roche, Teva, Voyager Therapeutics, Prothena, AbbVie, Impax Pharmaceuticals, MSD, UCB, GSK, Intec Pharma, Acadia, Adamas Therapeutics, Sunovion, NeuroDerm

Get sample of this report @ https://www.marketresearchupdate.com/sample/38746

Product Types:
Oral, Transdermal, Subcutaneous, Intestinal Infusion

By Application/ End-user:
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Regional Analysis For Parkinson’s Disease Treatment Market

North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Get Discount on Parkinson’s Disease Treatment report @ https://www.marketresearchupdate.com/discount/38746

  • The varying scenarios of the overall market have been depicted in this report, providing a roadmap of how the Parkinson’s Disease Treatment products secured their place in this rapidly-changing marketplace. Industry participants can reform their strategies and approaches by examining the market size forecast mentioned in this report. Profitable marketplaces for the Parkinson’s Disease Treatment Market have been revealed, which can affect the global expansion strategies of the leading organizations. However, each manufacturer has been profiled in detail in this research report.
  • Parkinson’s Disease Treatment Market Effect Factors Analysis chapter precisely gives emphasis on Technology Progress/Risk, Substitutes Threat, Consumer Needs/Customer Preference Changes, Technology Progress in Related Industry, and Economic/Political Environmental Changes that draw the growth factors of the Market.
  • The fastest & slowest growing market segments are pointed out in the study to give out significant insights into each core element of the market. Newmarket players are commencing their trade and are accelerating their transition in Parkinson’s Disease Treatment Market. Merger and acquisition activity forecast to change the market landscape of this industry.

This report comes along with an added Excel data-sheet suite taking quantitative data from all numeric forecasts presented in the report.

What’s in the offering: The report provides in-depth knowledge about the utilization and adoption of Parkinson’s Disease Treatment Industries in various applications, types, and regions/countries. Furthermore, the key stakeholders can ascertain the major trends, investments, drivers, vertical player’s initiatives, government pursuits towards the product acceptance in the upcoming years, and insights of commercial products present in the market.

Full Report Link @ https://www.marketresearchupdate.com/industry-growth/Parkinsons-Disease-Treatment-Market-38746

Lastly, the Parkinson’s Disease Treatment Market study provides essential information about the major challenges that are going to influence market growth. The report additionally provides overall details about the business opportunities to key stakeholders to expand their business and capture revenues in the precise verticals. The report will help the existing or upcoming companies in this market to examine the various aspects of this domain before investing or expanding their business in the Parkinson’s Disease Treatment market.

Contact Us:
Email : [email protected]